4//SEC Filing
Leggett Thomas 4
Accession 0001415889-25-008713
CIK 0001623526other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 6:17 PM ET
Size
8.1 KB
Accession
0001415889-25-008713
Insider Transaction Report
Form 4
Leggett Thomas
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-03-20+89,000→ 89,000 totalExercise: $8.33Exp: 2035-03-19→ Common Stock (89,000 underlying) - Award
Restricted Stock Units
2025-03-20+59,000→ 59,000 totalExp: 2029-03-20→ Common Stock (59,000 underlying)
Footnotes (3)
- [F1]The option shall vest as to 1/48 of the total award on April 15, 2025, with 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The award vests as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the issuer through each vesting date.
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
Related Parties
1- filerCIK 0001774690
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 6:17 PM ET
- Size
- 8.1 KB